Moody’s Corporation: Market Performance and Recent Corporate Developments

Market Summary (as of 07:45 PM CET, Wednesday 21 Oct 2026)

  • Closing price: USD 476.96 (down 1.23 % from the previous session).
  • Shares outstanding: 173.2 million.
  • Market capitalization: USD 83.4 billion.
  • Volume traded in last 24 h: USD 845 million.
  • Year‑to‑date change (since end‑of‑month): up 1.74 %.
  • 200‑day simple moving average: USD 468.73.
  • 52‑week high: USD 546.88 (15 Jan 2026).
  • 52‑week low: USD 402.28 (12 Feb 2026).

Recent Corporate Announcements

  • Upcoming earnings release: Moody’s will publish the results of its most recent quarter on 21 Oct 2026. Analysts predict a modest improvement in earnings per share relative to the previous year, with revenue expected to rise slightly.
  • Credit rating reaffirmation: The company’s rating agency reaffirmed several credit ratings for a major Indian bank, maintaining a stable outlook.
  • Share placement program: Moody’s issued a large number of ordinary shares to professional investors under a placement program. A small portion of these shares was allocated to senior directors. The share issuances were fully quoted on the Australian Stock Exchange.
  • No other material events: The latest disclosures did not highlight any additional operational or financial events beyond the share placement and forthcoming quarterly reporting.
TickerPrice ChangeCurrent PriceMarket CapP/E Ratio
MNST (Monster Beverage)+0.51 %USD 46.81USD 91.7 bn43.51
ELV (Elevance Health)+2.31 %USD 440.77USD 93.3 bn19.14
MRNA (Moderna)+6.69 %USD 249.77USD 90.6 bn–
HCA (HCA Healthcare)+2.39 %USD 461.23USD 98.5 bn15.27
PWR (Quanta Services)–3.62 %USD 603.47USD 93.0 bn70.43

Additional Context

  • Elevance Health is scheduled to speak at the UNLEASH 2026 event in Paris (20‑22 Oct), focusing on workforce innovation and technology integration.
  • Moderna’s recent surge contributed to gains in the NASDAQ 100 and S‑P 500, reflecting broader positive sentiment in the healthcare sector.
  • HCA Healthcare participated in the European Society for Medical Oncology meeting in Madrid, presenting preliminary findings on AI‑assisted imaging for lung cancer treatment assessment.

Company Profile

Moody’s Corporation, headquartered in New York, is a global credit rating, research, and risk analysis firm. Its services include credit ratings, quantitative risk measures, risk scoring software, credit portfolio management solutions, and securities pricing models. The company is listed on the New York Stock Exchange and was founded in 2000 following its IPO on 3 Oct 2000. For further information, visit www.moodys.com .